-

Lost Money in BillionToOne, Inc. (NASDAQ: BLLN)? Gibbs Mura is Investigating Potential Securities Law Violations on Behalf of BLLN Investors

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of BillionToOne, Inc. (“BillionToOne”) fell over 6% on November 18, 2026, after Fuzzy Panda Research published a report alleging that the company is the subject of an undisclosed state Medicaid fraud investigation and has engaged in improper billing practices. Gibbs Mura is investigating a potential BillionToOne (NASDAQ: BLLN) Securities Class Action Lawsuit concerning whether BillionToOne has violated federal securities laws by providing false or misleading statements to investors.

YOU MAY BE ABLE TO RECOVER YOUR LOSSES. VISIT OUR BILLIONTOONE CLASS ACTION LAWSUIT INVESTIGATION WEBPAGE OR CALL US AT (888) 410-2925 TO LEARN MORE.

What is the BillionToOne Legal Investigation About?

BillionToOne is a California-based molecular diagnostics company that sells blood tests for prenatal screening and cancer care. On November 18, 2026, Fuzzy Panda Research published a report alleging that Tennessee Medicaid’s Office of Program Integrity referred the company to state investigators for suspected fraud in 2024, after receiving eleven tips. According to the Fuzzy Panda report, Tennessee investigators found that “a credible allegation of fraud has been established,” due to a pattern of inappropriate billing and violations of state and federal False Claims Acts. Fuzzy Panda claims BillionToOne has never disclosed this investigation to investors.

The report further alleges that BillionToOne is billing for carrier testing at a “suspiciously high rate,” and may be illegally submitting claims to Medicaid for medically unnecessary testing.

Following this news, shares of BillionToOne dropped over 6% on November 18, 2026, causing harm to investors.

What Should BillionToOne Investors Do?

If you purchased BillionToOne (NASDAQ: BLLN) stock and lost money, visit our BillionToOne securities class action investigation page or contact our firm’s securities fraud attorneys at (888) 410-2925 to get more information about how you may be able to recover your losses. All calls are free and confidential.

About Gibbs Mura

Gibbs Mura represents investors nationwide in securities litigation and has more than two decades of experience prosecuting fraud. The firm has recovered billions of dollars for its clients against some of the world’s largest corporations, and our attorneys have received numerous honors for their work, including “Best Lawyers in America,” “Top Plaintiff Lawyers in California,” “California Lawyer Attorney of the Year,” “Class Action Practice Group of the Year,” “Consumer Protection MVP,” and “Top Women Lawyers in California.”

This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

PRESS CONTACT: DANI TISHKOFF
PHONE: 510.350.9723
EMAIL: DHTC@CLASSLAWGROUP.COM

Gibbs Mura

NASDAQ:BLLN

Release Summary
Gibbs Mura is investigating a potential securities class action lawsuit on behalf of BillionToOne (BLLN) investors.
Release Versions
$Cashtags

Contacts

PRESS CONTACT: DANI TISHKOFF
PHONE: 510.350.9723
EMAIL: DHTC@CLASSLAWGROUP.COM

More News From Gibbs Mura

Gibbs Mura Files Class Action Against Axon Over License Plate Surveillance

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura & co-counsel filed a lawsuit against Axon Enterprise alleging it unlawfully collects and shares CA drivers’ data through its ALPR cameras....

Landmark $100 Million Settlement Reached in Equifax Credit Score Misreporting Class Action Lawsuit; Gibbs Mura is Co-Lead Counsel on Behalf of 4 Million Estimated Class Members

OAKLAND, Calif.--(BUSINESS WIRE)--On August 17, 2026, a federal judge granted preliminary approval to a $100 million settlement in a class action lawsuit against Equifax brought by Gibbs Mura and co-counsel alleging it miscalculated credit scores affecting approximately 4 million people in 2022. This is the largest settlement in history related to the Fair Credit Reporting Act (FCRA) and a landmark achievement in consumer protection. Gibbs Mura partner David Berger, court-appointed to co-lead t...

Character.AI Charged With Teen Mental Health Harm in Lawsuit by Gibbs Mura, A Law Group

OAKLAND, Calif.--(BUSINESS WIRE)--National law firm Gibbs Mura has filed a lawsuit alleging that AI chatbot platform Character.AI poses serious risks to children and teenagers. The Character.AI lawsuit complaint alleges that interactions with Character.AI chatbots can cause or contribute to severe injuries, including addiction, depression, anxiety, self-harm, suicidal ideation, and sexual exploitation. Gibbs Mura continues to investigate potential claims on behalf of families whose children hav...
Back to Newsroom